Original language | English |
---|---|
Pages (from-to) | 425-432 |
Number of pages | 8 |
Journal | Breast Cancer Research and Treatment |
Volume | 159 |
Issue number | 3 |
DOIs | |
Publication status | Published - Oct 1 2016 |
Externally published | Yes |
ASJC Scopus Subject Areas
- Oncology
- Cancer Research
Fingerprint
Dive into the research topics of 'Cost-effectiveness of febrile neutropenia prevention with primary versus secondary G-CSF prophylaxis for adjuvant chemotherapy in breast cancer: a systematic review'. Together they form a unique fingerprint.Cite this
Younis, T., Rayson, D., Jovanovic, S., & Skedgel, C. (2016). Cost-effectiveness of febrile neutropenia prevention with primary versus secondary G-CSF prophylaxis for adjuvant chemotherapy in breast cancer: a systematic review. Breast Cancer Research and Treatment, 159(3), 425-432. https://doi.org/10.1007/s10549-016-3954-1